Pregnancy and Neonatal Outcomes after Fetal Exposure To Biologics and Thiopurines among Women with Inflammatory Bowel Disease

BACKGROUND: Pregnant women with inflammatory bowel disease (IBD) may require biologic or thiopurine therapy to control disease activity. Lack of safety data has led to therapy discontinuation during pregnancy with health repercussions to mother and child. METHODS: Between 2007 and 2019, pregnant wom...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Gastroenterology
Auteurs principaux: Mahadevan, Uma, Long, Millie D., Kane, Sunanda V., Roy, Abhik, Dubinsky, Marla C., Sands, Bruce E., Cohen, Russell D., Chambers, Christina D., Sandborn, William J.
Format: Artigo
Langue:Inglês
Publié: 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7956164/
https://ncbi.nlm.nih.gov/pubmed/33227283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2020.11.038
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires